11-77084907-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The NM_004055.5(CAPN5):āc.21C>Gā(p.Pro7=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00125 in 1,613,966 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.00070 ( 0 hom., cov: 33)
Exomes š: 0.0013 ( 2 hom. )
Consequence
CAPN5
NM_004055.5 synonymous
NM_004055.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.07
Genes affected
CAPN5 (HGNC:1482): (calpain 5) Calpains are calcium-dependent cysteine proteases involved in signal transduction in a variety of cellular processes. A functional calpain protein consists of an invariant small subunit and 1 of a family of large subunits. CAPN5 is one of the large subunits. Unlike some of the calpains, CAPN5 and CAPN6 lack a calmodulin-like domain IV. Because of the significant similarity to Caenorhabditis elegans sex determination gene tra-3, CAPN5 is also called as HTRA3. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 11-77084907-C-G is Benign according to our data. Variant chr11-77084907-C-G is described in ClinVar as [Benign]. Clinvar id is 1168849.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr11-77084907-C-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-1.07 with no splicing effect.
BS2
High AC in GnomAd4 at 107 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPN5 | NM_004055.5 | c.21C>G | p.Pro7= | synonymous_variant | 2/13 | ENST00000648180.1 | NP_004046.2 | |
CAPN5 | XM_011545225.1 | c.141C>G | p.Pro47= | synonymous_variant | 3/14 | XP_011543527.1 | ||
CAPN5 | XM_017018223.3 | c.129C>G | p.Pro43= | synonymous_variant | 2/13 | XP_016873712.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPN5 | ENST00000648180.1 | c.21C>G | p.Pro7= | synonymous_variant | 2/13 | NM_004055.5 | ENSP00000498132 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000703 AC: 107AN: 152192Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
107
AN:
152192
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000561 AC: 141AN: 251214Hom.: 0 AF XY: 0.000523 AC XY: 71AN XY: 135884
GnomAD3 exomes
AF:
AC:
141
AN:
251214
Hom.:
AF XY:
AC XY:
71
AN XY:
135884
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00131 AC: 1908AN: 1461774Hom.: 2 Cov.: 33 AF XY: 0.00121 AC XY: 879AN XY: 727190
GnomAD4 exome
AF:
AC:
1908
AN:
1461774
Hom.:
Cov.:
33
AF XY:
AC XY:
879
AN XY:
727190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000703 AC: 107AN: 152192Hom.: 0 Cov.: 33 AF XY: 0.000605 AC XY: 45AN XY: 74354
GnomAD4 genome
AF:
AC:
107
AN:
152192
Hom.:
Cov.:
33
AF XY:
AC XY:
45
AN XY:
74354
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
CAPN5-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 14, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at